Christopher M. Starr

Director

Director at Monopar Therapeutics, filing insider transactions on 2026-10-01.

Total Purchases

—

0 transactions

Total Sales

$659K

3 transactions

Companies Traded

1

3 total filings

Active Since

2026-10-01

Last: 2026-10-01

Companies

Monopar Therapeutics

Other Reporting Insiders at Monopar Therapeutics

Transaction History

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-10-01	MNPR	Sale	2,970	$78.82	$234K	5,972	SEC ↗
2026-10-01	MNPR	Sale	4,631	$78.09	$362K	8,942	SEC ↗
2026-10-01	MNPR	Sale	799	$79.67	$64K	5,173

Christopher M. Starr (Monopar Therapeutics) Insider Trades | Tormere